See more : Apar Industries Limited (APARINDS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of InfuSystem Holdings, Inc. (INFU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InfuSystem Holdings, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Sterling Metals Corp. (SAGGF) Income Statement Analysis – Financial Results
- AirIQ Inc. (IQ.V) Income Statement Analysis – Financial Results
- US Lighting Group, Inc. (USLG) Income Statement Analysis – Financial Results
- Cohen & Steers Infrastructure Fund, Inc (UTF) Income Statement Analysis – Financial Results
- Aurelia Metals Limited (AMI.AX) Income Statement Analysis – Financial Results
InfuSystem Holdings, Inc. (INFU)
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 125.79M | 109.91M | 102.38M | 97.39M | 81.12M | 67.14M | 71.08M | 70.50M | 72.13M | 66.49M | 62.28M | 58.83M | 54.64M | 47.23M | 38.96M | 35.42M | 6.58M | 0.00 | 0.00 |
| Cost of Revenue | 62.68M | 47.34M | 42.19M | 38.63M | 34.23M | 28.12M | 27.72M | 25.76M | 20.94M | 19.13M | 18.60M | 15.92M | 19.28M | 13.68M | 10.33M | 9.19M | 1.62M | 0.00 | 0.00 |
| Gross Profit | 63.11M | 62.57M | 60.20M | 58.76M | 46.88M | 39.02M | 43.36M | 44.74M | 51.18M | 47.35M | 43.68M | 42.91M | 35.36M | 33.55M | 28.64M | 26.22M | 4.96M | 0.00 | 0.00 |
| Gross Profit Ratio | 50.17% | 56.93% | 58.80% | 60.33% | 57.80% | 58.12% | 61.01% | 63.46% | 70.97% | 71.22% | 70.13% | 72.94% | 64.71% | 71.03% | 73.50% | 74.05% | 75.39% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 45.38M | 46.08M | 42.26M | 35.20M | 29.02M | 24.85M | 25.20M | 24.63M | 23.78M | 19.99M | 18.97M | 23.06M | 17.99M | 20.62M | 12.22M | 11.77M | 4.89M | 919.22B | 0.00 |
| Selling & Marketing | 12.65M | 12.26M | 10.78M | 9.66M | 9.93M | 9.11M | 9.78M | 9.66M | 10.42M | 9.75M | 9.66M | 9.86M | 9.37M | 7.09M | 5.26M | 4.66M | 649.00K | -919.20B | 0.00 |
| SG&A | 58.03M | 58.34M | 53.04M | 44.86M | 38.96M | 33.95M | 34.98M | 34.29M | 34.20M | 29.73M | 28.63M | 32.93M | 27.36M | 27.71M | 17.48M | 16.42M | 6.12M | 20.82M | 24.48K |
| Other Expenses | 990.00K | 2.58M | 4.34M | 5.08M | 4.40M | -37.00K | -113.00K | 6.00K | 13.00K | 13.00K | 301.00K | -141.00K | 6.76M | 6.77M | 5.83M | 5.01M | 6.46M | 20.82M | 0.00 |
| Operating Expenses | 59.02M | 60.92M | 57.38M | 49.93M | 43.36M | 38.60M | 46.18M | 43.77M | 42.32M | 38.02M | 37.78M | 40.91M | 34.12M | 34.48M | 23.31M | 21.44M | 6.46M | 20.82M | 24.48K |
| Cost & Expenses | 121.70M | 108.26M | 99.56M | 88.56M | 77.59M | 66.72M | 73.90M | 69.52M | 63.26M | 57.16M | 56.38M | 56.83M | 53.40M | 48.17M | 33.64M | 30.63M | 8.08M | 20.82M | 24.48K |
| Interest Income | 0.00 | 1.40M | 1.38M | 1.26M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00K | 36.00K | 3.88M | 3.20M | 0.00 |
| Interest Expense | 2.17M | 1.40M | 1.38M | 1.26M | 1.90M | 1.42M | 1.33M | 1.34M | 1.71M | 3.13M | 3.50M | 3.34M | 2.19M | 3.35M | 3.50M | 3.77M | 774.00K | 1.30K | 300.00 |
| Depreciation & Amortization | 12.51M | 13.36M | 14.63M | 14.03M | 12.34M | 11.31M | 12.52M | 10.74M | 8.24M | 6.14M | 8.03M | 8.40M | 9.05M | 8.60M | 6.44M | 6.40M | 862.00K | 6.66M | 0.00 |
| EBITDA | 16.50M | 15.09M | 17.15M | 22.82M | 15.77M | 11.69M | 8.60M | 11.72M | 13.94M | 15.49M | 14.23M | 9.45M | -57.34M | 7.75M | 11.69M | 20.40M | -635.00K | -6.82M | -24.48K |
| EBITDA Ratio | 13.11% | 13.55% | 16.86% | 23.44% | 19.44% | 17.41% | 13.49% | 16.63% | 23.74% | 23.29% | 22.85% | 17.44% | 18.82% | 16.21% | 30.22% | 31.70% | 40.40% | 0.00% | 0.00% |
| Operating Income | 4.09M | 1.65M | 2.82M | 8.83M | 3.53M | 415.00K | -3.81M | 974.00K | 8.86M | 9.33M | 5.90M | 2.00M | -66.36M | -938.00K | 5.33M | 4.79M | -1.50M | -20.82M | -24.48K |
| Operating Income Ratio | 3.25% | 1.50% | 2.75% | 9.06% | 4.35% | 0.62% | -5.36% | 1.38% | 12.29% | 14.03% | 9.47% | 3.40% | -121.45% | -1.99% | 13.67% | 13.51% | -22.74% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.24M | -1.52M | -1.56M | -1.28M | -2.00M | -1.46M | -1.45M | -1.34M | -3.29M | -3.12M | -3.20M | -4.15M | -2.22M | -2.29M | -3.58M | 6.08M | -189.00K | -6,821.45B | 0.00 |
| Income Before Tax | 1.85M | 130.00K | 1.26M | 7.54M | 1.52M | -1.04M | -5.26M | -364.00K | 5.57M | 6.21M | 2.70M | -2.15M | -68.58M | -3.22M | 1.75M | 10.87M | -1.69M | -6.82M | 0.00 |
| Income Before Tax Ratio | 1.47% | 0.12% | 1.23% | 7.75% | 1.88% | -1.55% | -7.40% | -0.52% | 7.73% | 9.34% | 4.34% | -3.66% | -125.51% | -6.82% | 4.49% | 30.68% | -25.62% | 0.00% | 0.00% |
| Income Tax Expense | 979.00K | 112.00K | -163.00K | -9.79M | 163.00K | 53.00K | 15.45M | -142.00K | 1.83M | 2.85M | 1.03M | -663.00K | -23.13M | -1.37M | 977.00K | 907.00K | 1.11M | 1.04M | 24.78K |
| Net Income | 872.00K | 18.00K | 1.42M | 17.33M | 1.36M | -1.10M | -20.71M | -222.00K | 3.74M | 3.36M | 1.67M | -1.49M | -45.44M | -1.85M | 774.00K | 9.96M | -2.80M | -7.86M | -24.78K |
| Net Income Ratio | 0.69% | 0.02% | 1.39% | 17.80% | 1.68% | -1.63% | -29.13% | -0.31% | 5.19% | 5.05% | 2.68% | -2.53% | -83.17% | -3.92% | 1.99% | 28.12% | -42.48% | 0.00% | 0.00% |
| EPS | 0.04 | 0.00 | 0.07 | 0.86 | 0.07 | -0.05 | -0.91 | -0.01 | 0.17 | 0.15 | 0.08 | -0.07 | -2.16 | -0.09 | 0.04 | 0.56 | -0.15 | -0.58 | -0.01 |
| EPS Diluted | 0.04 | 0.00 | 0.06 | 0.80 | 0.07 | -0.05 | -0.91 | -0.01 | 0.16 | 0.15 | 0.08 | -0.07 | -2.16 | -0.09 | 0.04 | 0.53 | -0.15 | -0.58 | -0.01 |
| Weighted Avg Shares Out | 21.02M | 20.65M | 20.52M | 20.11M | 19.73M | 21.42M | 22.74M | 22.20M | 22.41M | 22.15M | 21.87M | 21.27M | 21.07M | 19.72M | 18.61M | 17.94M | 18.30M | 13.66M | 3.25M |
| Weighted Avg Shares Out (Dil) | 21.65M | 21.55M | 22.05M | 21.72M | 20.84M | 21.42M | 22.74M | 22.62M | 22.84M | 22.55M | 22.07M | 21.43M | 21.07M | 19.72M | 18.93M | 18.67M | 18.30M | 13.66M | 3.25M |
InfuSystem Holdings Inc. (INFU) Q1 2023 Earnings Call Transcript
InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023
InfuSystem: Disappointing 2022 Results Lead To Bargain Prices
My Top Small-Cap Ideas For 2023
InfuSystem Holdings Inc. (INFU) Q3 2022 Earnings Call Transcript
InfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022
InfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q2 2022 Results Earnings Call Transcript
InfuSystem Reports Second Quarter 2022 Financial Results
Source: https://incomestatements.info
Category: Stock Reports